Skip to main content
TipRanks
Go Ultimate75% OFF

Paul R Gray Insider Profile

4 Followers

Paul R Gray, Former Director at United Therapeutics, holds 0.00 shares in United Therapeutics (Ticker: UTHR). Most recently, Paul R Gray Sold 7,500 shares of United Therapeutics on Nov 07, 2013 for an estimated value of $677.55K.

Paul R Gray's Trading History

UTHR
United Therapeutics
Nov 07, 2013Former DirectorInformative Sell677.55K$0.00
UTHR
Insider Shares: 0.00 (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 07, 2013Informative Sell$677.55K7,500$90.34-41.70%
Aug 02, 2013Informative Sell$561.98K7,500$74.93-16.70%
May 05, 2011Informative Sell$4.48M66,000$67.94+36.20%
May 02, 2011Uninformative Sell$136.50K2,000$68.25―
Apr 04, 2011Uninformative Sell$134.58K2,000$67.29―

You May Also Like

Paul R Gray insider profile FAQ

What is the percentage of profitable transactions made by Paul R Gray?
The percentage of profitable transactions made by Paul R Gray is 20%.
What is the average return per transaction made by Paul R Gray?
The average return per transaction made by Paul R Gray is -12.70%.
What stocks does Paul R Gray hold?
Paul R Gray holds: UTHR stocks.
What was Paul R Gray’s latest transaction?
Paul R Gray’s latest transaction was an Informative Sell of $677.55K.
What was Paul R Gray's most profitable transaction?
Paul R Gray’s most profitable transaction was an Informative Sell of UTHR stock on May 5, 2011. The return on the trade was 36.20%.
What is Paul R Gray's role in United Therapeutics?
Paul R Gray's role in United Therapeutics is Former Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.